Advertisement

The association between eosinophil count, serum lipids and metabolic syndrome in Taiwanese

  • Wei-Yu Lin
    Affiliations
    Department of Family Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
    Search for articles by this author
  • Jong-Dar Chen
    Correspondence
    Corresponding author at: Jong-Dar Chen, MD, Department of Family Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan; Department of Medicine, Fu Jen Catholic University, Taipei, Taiwan; No. 95, Wen Chang Road, Shih Lin District, Taipei City
    Affiliations
    Department of Family Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan

    Department of Medicine, School of Medicine, Fu Jen Catholic University, Taipei, Taiwan
    Search for articles by this author

      Abstract

      Background

      Eosinophil count, dyslipidemia, and metabolic syndrome (MetS) are associated with systemic inflammation. We conducted this large population-based study to investigate the association between elevated eosinophil count, serum lipids, and MetS in the Taiwanese population.

      Methods

      A cross-sectional study of 10,357 adults who underwent health checkups at Shin Kong Wu Ho-Su Memorial Hospital in Taiwan between January 2006 and December 2016 was conducted. MetS was defined according to criteria modified by the International Diabetes Federation specifically for the Chinese population. The measurement of serum lipids included high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), apolipoprotein A-I (ApoA-I), and apolipoprotein B (ApoB). Pearson's correlation and linear regression were used to determine the association of eosinophil count with waist circumference, blood pressure, fasting glucose, and serum lipids. Multivariate logistic regression analysis was used to determine the odds ratio of MetS and abnormal serum lipid levels in each eosinophil count quartile.

      Results

      Eosinophil count was positively associated with triglycerides levels and negatively associated with HDL-C levels; however, it was not significantly associated with ApoA-I and ApoB. The odds ratio of MetS increased significantly across eosinophil count quartiles. The adjusted odds ratios of MetS for the second, third, and fourth quartiles were 1.28, 1.38, and 1.42, respectively, with reference to the first quartile.

      Conclusions

      High eosinophil count is an independent risk factor for MetS. Hypertriglyceridemia and hypo-HDL-cholesterolemia might partly contribute to this result.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ramirez G.A.
        • Yacoub M.R.
        • Ripa M.
        • et al.
        Eosinophils from Physiology to Disease: A Comprehensive Review.
        Biomed Res Int. 2018; 9095275https://doi.org/10.1155/2018/9095275
        • Yang B.G.
        • Seoh J.Y.
        • Jang M.H.
        Regulatory eosinophils in inflammation and metabolic disorders.
        Immune Netw. 2017; 17: 41-47
        • Guo C.
        • Bochner B.S.
        Workup for eosinophilia.
        Allergy Asthma Proc. 2019; 40: 429-432
        • Kovalszki A.
        • Weller P.F.
        Eosinophilia.
        Prim Care. 2016; 43: 607-617
        • Roufosse F.
        • Weller P.F.
        Practical approach to the patient with hypereosinophilia.
        J Allergy Clin Immunol. 2010; 126: 39-44
        • Oda E.
        The metabolic syndrome as a concept of adipose tissue disease.
        Hypertens Res. 2008; 31: 1283-1291
        • Dandona P.
        • Aljada A.
        • Chaudhuri A.
        • et al.
        Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and inflammation.
        Circulation. 2005; 111: 1448-1454
        • Ross R.
        Atherosclerosis - An inflammatory disease.
        N Engl J Med. 1999; 340: 115-126
        • Horne B.D.
        • Anderson J.L.
        • John J.M.
        • et al.
        Which white blood cell subtypes predict increased cardiovascular risk?.
        J Am Coll Cardiol. 2005; 45: 1638-1643
        • Amini M.
        • Bashirova D.
        • Prins B.P.
        • et al.
        Eosinophil count is a common factor for complex metabolic and pulmonary traits and diseases: The lifelines cohort study.
        PLoS ONE. 2016; 11: 1-15
        • Kim D.J.
        • Noh J.H.
        • Lee B.W.
        • et al.
        The associations of total and differential white blood cell counts with obesity, hypertension, dyslipidemia and glucose intolerance in a Korean population.
        J Korean Med Sci. 2008; 23: 193-198
        • Babio N.
        • Ibarrola-Jurado N.
        • Bulló M.
        • et al.
        White Blood Cell Counts as Risk Markers of Developing Metabolic Syndrome and Its Components in the Predimed Study.
        PLoS ONE. 2013; 8: e58354
        • Shim W.S.
        • Kim H.J.
        • Kang E.S.
        • et al.
        The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients.
        Diabetes Res Clin Pract. 2006; 73: 284-291
        • Meng W.
        • Zhang C.
        • Zhang Q.
        • et al.
        Association between Leukocyte and Metabolic Syndrome in Urban Han Chinese: A Longitudinal Cohort Study.
        PLoS ONE. 2012; 7: 1-7
        • Kim J.A.
        • Choi Y.S.
        • Hong J.I.
        • et al.
        Association of metabolic syndrome with white blood cell subtype and red blood cells.
        Endocr J. 2006; 53: 133-139
        • Fukui M.
        • Tanaka M.
        • Hamaguchi M.
        • et al.
        Eosinophil count is positively correlated with albumin excretion rate in men with type 2 diabetes.
        Clin J Am Soc Nephrol. 2009; 4: 1761-1765
        • Huang Z.S.
        • Chien K.L.
        • Yang C.Y.
        • et al.
        Peripheral differential leukocyte counts in humans vary with hyperlipidemia, smoking, and body mass index.
        Lipids. 2001; 36: 237-245
        • Rahim S.
        • Abdullah H.M.A.
        • Ali Y.
        • et al.
        Serum Apo A-1 and Its Role as a Biomarker of Coronary Artery Disease.
        Cureus. 2016; 8: e941
        • Chan D.C.
        • Watts G.F.
        Apolipoproteins as markers and managers of coronary risk.
        QJM. 2006; 99: 277-287
      1. The International Diabetes Federation (IDF). The IDF consensus worldwide definition of the metabolic syndrome,https://www.idf.org/our-activities/advocacy-awareness/resources-and-tools/60:idfconsensus-worldwide-definitionof-the-metabolic-syndrome.html; 2017 [accessed 20. 01.15].

        • Exley M.A.
        • Hand L.
        • O'Shea D.
        • et al.
        Interplay between the immune system and adipose tissue in obesity.
        J Endocrinol. 2014; 223: R41-R48
        • Jacobsen E.A.
        • Zellner K.R.
        • Colbert D.
        • Lee J.J.
        Eosinophils Regulate Dendritic Cells and Th2 Pulmonary Immune Responses following Allergen Provocation.
        J Immunol. 2011; 187: 6059-6068
        • Feingold K.R.
        • Doerrler W.
        • Dinarello C.A.
        • et al.
        Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis.
        Endocrinology. 1992; 130: 10-16
        • Kawakami M.
        • Cerami A.
        Studies of endotoxin-induced decrease in lipoprotein lipase activity.
        J Exp Med. 1981; 154: 631-639
        • Barter P.J.
        • Rye K.-A.
        The rationale for using apoA-I as a clinical marker of cardiovascular risk.
        J Intern Med. 2006; 259: 447-454
        • Shapiro M.D.
        • Fazio S.
        Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease.
        F1000Res. 2017; 6: 134
        • Barochia A.V.
        • Gordon E.M.
        • Kaler M.
        • et al.
        High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics.
        J Lipid Res. 2017; 58: 1713-1721